Goldman Sachs Legal Resource Center

Seeger Weiss is presently investigating the sales practices and marketing of a synthetic CDO called ABACUS 2007-AC1 ("ABACUS 2007") by Goldman Sachs (NYSE: GS). On April 16, 2010, the SEC brought a securities fraud action against Goldman Sachs for "making materially misleading statements and omissions in connection with [ABACUS 2007]". Goldman Sachs structured and marketed ABACUS 2007 to investors.

Retail and institutional investors who have sustained losses in Goldman Sachs' ABACUS ABS CDO program should contact Seeger Weiss to explore their legal rights and options. Call us toll free at (888) 584-0411 or fill out our free case evaluation form. Attorney consultations incur no obligation on your part and all initial consultations are free of charge.

• Seeger Weiss Wins 5th Verdict Against Accutane Maker, Dealing a $25.16 Million Blow
• Seeger Weiss Delivers $11 Million Verdict to Small, Family Farms Overrun by Corporate Agriculture's Waste
• Seeger Weiss Obtains $41.5 Million Global Resolution of Zetia and Vytorin Claims
• Seeger Weiss Secures $4.85 Billion Vioxx Settlement from Merck
• Seeger Weiss Named to National Law Journal's Plaintiffs' Hot List Three Years Running
• Seeger Weiss & Milberg Drive Bernie Madoff into Personal Bankruptcy